合成免疫市場：2024-2034年

世界の合成免疫の市場規模は、2034年にかけてCAGR 25.6％で成長すると予測されています。

バイオテクノロジーの進歩が市場成長を牽引：

合成生物学、遺伝子編集、免疫療法における技術の進歩は、特に合成免疫の新興分野において、医療の展望に革命をもたらしています。合成生物学の技術は、研究者に生物学的分子の設計と構築に関するかつてない制御を提供し、特定の治療ニーズに合わせた新規合成分子の創出を可能にします。バイオ医薬品は業界をリードしており、2023年には市場収益の41％超のシェアを示しました。生物製剤は、FDAによる新薬承認数で従来の医薬品を上回っています。合成抗体、サイトカイン、受容体を工学的に設計することにより、研究者は免疫細胞、経路、疾患抗原を正確に標的化し、有効性と特異性を高めることができます。CRISPR-Cas9のような遺伝子編集技術により、研究者はT細胞のような免疫細胞の遺伝子コードを改変し、疾患細胞を認識・排除する能力を高めることができます。このような標的を絞ったアプローチにより、オフターゲット効果を最小限に抑え、免疫療法の全体的な効果を向上させることができます。

合成免疫の高い開発コストが産業成長の妨げとなる可能性：

合成免疫療法や診断ツールの開発には、早期発見から臨床試験、薬事承認に至るまで、複数の段階にわたるR&Dに多額の投資が必要となります。主要なコスト要因の一つは、望ましい治療・診断特性を持つ合成分子を設計、設計、製造するための最先端技術と専門知識の必要性です。これには、高度な実験設備、計算ツール、合成生物学、遺伝子編集、免疫学に熟練した専門人材への投資が含まれます。さらに、合成免疫療法や診断薬の安全性や有効性を評価するための臨床試験の実施は、R&D費のかなりの部分を占めています。臨床試験には、患者のリクルート、データの収集と分析、適正臨床基準 (GCP) の遵守など、広範なリソースが必要です。

当レポートでは、世界の合成免疫の市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

• 主な調査結果
• 市場力学
• 影響分析
  • 市場牽引要因
  • 市場抑制要因
  • 市場機会
• サプライチェーン分析
• 規制の枠組み
• 新興市場とメガトレンド
• ポーターのファイブフォース分析
• PEST分析

第4章 合成免疫市場の分析：タイプ別

• 主要調査結果
• 市場魅力度指数
• 市場規模の推移・予測
• 合成抗体
• 合成ワクチン
• 合成アジュバント
• 合成免疫調節剤
• その他
  • 市場規模の推移・予測：地域別
  • 市場シェア：地域別

第5章 合成免疫市場の分析：用途別

• 主要調査結果
• 市場魅力度指数
• 市場規模の推移・予測
• 感染症
• 自己免疫疾患
• 癌
• アレルギー
• その他
  • 市場規模の推移・予測：地域別
  • 市場シェア：地域別

第6章 合成免疫市場の分析：エンドユーザー別

• 主要調査結果
• 市場魅力度指数
• 市場規模の推移・予測
• 病院
• クリニック
• 研究機関
• その他
  • 市場規模の推移・予測：地域別
  • 市場シェア：地域別

第7章 合成免疫市場の分析：地域別

• 主要調査結果
• 市場規模の推移・予測

第8章 北米の合成免疫市場の分析

第9章 欧州の合成免疫市場の分析

第10章 アジア太平洋の合成免疫市場の分析

第11章 ラテンアメリカの合成免疫市場の分析

第12章 中東・アフリカの合成免疫市場の分析

第13章 企業プロファイル

• 競合情勢
• 戦略的展望
• ADC Therapeutics
• BioNTech SE
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• Synthego
• GenScript Biotech Corporation
• Ginkgo Bioworks
• Inscripta, Inc.
• Moderna, Inc.
• Synlogic Therapeutics
• Evonetix Ltd.
• Sherlock Biosciences
• Mission Therapeutics
• Camena Bioscience
• Mammoth Biosciences

第14章 総論・提言

• Visiongainからの総論
• 市場参入企業への提言

List of Tables

• Table 1 Synthetic Immunology Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
• Table 2 Chronic Diseases Statistics, 2023
• Table 3 Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 4 Synthetic Antibodies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 5 Synthetic Vaccines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 6 Synthetic Adjuvants Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 7 Synthetic Immunomodulators Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 8 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 9 Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 10 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 11 Autoimmune Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 12 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 13 Allergies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 14 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 15 Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 16 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 17 Clinics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 18 Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 19 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 20 Synthetic Immunology Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 21 North America Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 22 North America Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 23 North America Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 24 North America Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 25 U.S. Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 26 Canada Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 27 Europe Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 28 Europe Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 29 Europe Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 30 Europe Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 31 Germany Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 32 France Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 33 UK Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 34 Italy Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 35 Spain Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 36 Russia Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 37 Rest of Europe Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 38 Asia Pacific Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 39 Asia Pacific Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 40 Asia Pacific Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 41 Asia Pacific Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 42 Japan Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 43 China Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 44 India Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 45 Australia Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 46 South Korea Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 47 Singapore Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 48 Rest of Asia Pacific Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 49 Latin America Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 50 Latin America Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 51 Latin America Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 52 Latin America Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 53 Brazil Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 54 Mexico Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 55 Argentina Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 56 Colombia Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 57 Rest of Latin America Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 58 MEA Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 59 MEA Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 60 MEA Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 61 MEA Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 62 GCC Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 63 South Africa Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 64 Rest of MEA Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
• Table 65 Strategic Outlook
• Table 66 ADC Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 67 ADC Therapeutics: Product Benchmarking
• Table 68 ADC Therapeutics: Strategic Outlook
• Table 69 BioNTech SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 70 BioNTech SE: Product Benchmarking
• Table 71 BioNTech SE: Strategic Outlook
• Table 72 CRISPR Therapeutics AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 73 CRISPR Therapeutics AG: Product Benchmarking
• Table 74 Editas Medicine, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 75 Editas Medicine, Inc.: Product Benchmarking
• Table 76 Editas Medicine, Inc.: Strategic Outlook
• Table 77 Synthego: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 78 Synthego: Product Benchmarking
• Table 79 GenScript Biotech Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 80 GenScript Biotech Corporation: Product Benchmarking
• Table 81 GenScript Biotech Corporation: Strategic Outlook
• Table 82 Ginkgo Bioworks: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 83 Ginkgo Bioworks: Product Benchmarking
• Table 84 Ginkgo Bioworks: Strategic Outlook
• Table 85 Inscripta, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 86 Inscripta, Inc.: Product Benchmarking
• Table 87 Inscripta, Inc.: Strategic Outlook
• Table 88 Moderna, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 89 Moderna, Inc.: Product Benchmarking
• Table 90 Moderna, Inc.: Strategic Outlook
• Table 91 Synlogic Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 92 Synlogic Therapeutics: Product Benchmarking
• Table 93 Evonetix Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 94 Evonetix Ltd.: Product Benchmarking
• Table 95 Sherlock Biosciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 96 Sherlock Biosciences: Product Benchmarking
• Table 97 Mission Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 98 Mission Therapeutics: Product Benchmarking
• Table 99 Camena Bioscience: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 100 Camena Bioscience: Product Benchmarking
• Table 101 Mammoth Biosciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
• Table 102 Mammoth Biosciences: Product Benchmarking

List of Figures

• Figure 1 Synthetic Immunology Market Segmentation
• Figure 2 Synthetic Immunology Market by Type: Market Attractiveness Index
• Figure 3 Synthetic Immunology Market by Application: Market Attractiveness Index
• Figure 4 Synthetic Immunology Market by End-User: Market Attractiveness Index
• Figure 5 Synthetic Immunology Market Attractiveness Index by Region
• Figure 6 Synthetic Immunology Market: Market Dynamics
• Figure 7 Synthetic Immunology Market: Impact Analysis
• Figure 8 Synthetic Immunology Market: Supply Chain Analysis
• Figure 9 Synthetic Immunology Market: Porter's Five Forces Analysis
• Figure 10 Synthetic Immunology Market: PEST Analysis
• Figure 11 Synthetic Immunology Market by Type: Market Attractiveness Index
• Figure 12 Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
• Figure 13 Synthetic Immunology Market Share Forecast by Type, 2024, 2029, 2034 (%)
• Figure 14 Synthetic Antibodies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 15 Synthetic Antibodies Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 16 Synthetic Vaccines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 17 Synthetic Vaccines Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 18 Synthetic Adjuvants Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 19 Synthetic Adjuvants Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 20 Synthetic Immunomodulators Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 21 Synthetic Immunomodulators Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 22 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 23 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 24 Synthetic Immunology Market by Application: Market Attractiveness Index
• Figure 25 Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
• Figure 26 Synthetic Immunology Market Share Forecast by Application, 2024, 2029, 2034 (%)
• Figure 27 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 28 Infectious Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 29 Autoimmune Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 30 Autoimmune Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 31 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 32 Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 33 Allergies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 34 Allergies Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 35 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 36 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 37 Synthetic Immunology Market by End-users: Market Attractiveness Index
• Figure 38 Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR %)
• Figure 39 Synthetic Immunology Market Share Forecast by End-User, 2024, 2029, 2034 (%)
• Figure 40 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 41 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 42 Clinics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 43 Clinics Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 44 Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 45 Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 46 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 47 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
• Figure 48 Synthetic Immunology Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
• Figure 49 Synthetic Immunology Market Share Forecast by Region 2024, 2029, 2034 (%)
• Figure 50 Synthetic Immunology Market by Region, 2024-2034 (US$ Billion, AGR %)
• Figure 51 North America Synthetic Immunology Market Attractiveness Index
• Figure 52 North America Synthetic Immunology Market by Region, 2024, 2029 & 2034 (US$ Billion)
• Figure 53 North America Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
• Figure 54 North America Synthetic Immunology Market Share Forecast by Country, 2024 & 2034 (%)
• Figure 55 North America Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
• Figure 56 North America Synthetic Immunology Market Share Forecast by Type, 2024 & 2034 (%)
• Figure 57 North America Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
• Figure 58 North America Synthetic Immunology Market Share Forecast by Application, 2024 & 2034 (%)
• Figure 59 North America Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR %)
• Figure 60 North America Synthetic Immunology Market Share Forecast by End-User, 2024 & 2034 (%)
• Figure 61 U.S. Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 62 Canada Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 63 Europe Synthetic Immunology Market Attractiveness Index
• Figure 64 Europe Synthetic Immunology Market by Region, 2024, 2029 & 2034 (US$ Billion)
• Figure 65 Europe Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
• Figure 66 Europe Synthetic Immunology Market Share Forecast by Country, 2024 & 2034 (%)
• Figure 67 Europe Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
• Figure 68 Europe Synthetic Immunology Market Share Forecast by Type, 2024 & 2034 (%)
• Figure 69 Europe Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
• Figure 70 Europe Synthetic Immunology Market Share Forecast by Application, 2024 & 2034 (%)
• Figure 71 Europe Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR %)
• Figure 72 Europe Synthetic Immunology Market Share Forecast by End-User, 2024 & 2034 (%)
• Figure 73 Germany Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 74 France Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 75 UK Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 76 Italy Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 77 Spain Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 78 Russia Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 79 Rest of Europe Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 80 Asia Pacific Synthetic Immunology Market Attractiveness Index
• Figure 81 Asia Pacific Synthetic Immunology Market by Region, 2024, 2029 & 2034 (US$ Billion)
• Figure 82 Asia Pacific Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
• Figure 83 Asia Pacific Synthetic Immunology Market Share Forecast by Country, 2024 & 2034 (%)
• Figure 84 Asia Pacific Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
• Figure 85 Asia Pacific Synthetic Immunology Market Share Forecast by Type, 2024 & 2034 (%)
• Figure 86 Asia Pacific Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
• Figure 87 Asia Pacific Synthetic Immunology Market Share Forecast by Application, 2024 & 2034 (%)
• Figure 88 Asia Pacific Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR %)
• Figure 89 Asia Pacific Synthetic Immunology Market Share Forecast by End-User, 2024 & 2034 (%)
• Figure 90 Japan Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 91 China Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 92 India Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 93 Australia Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 94 South Korea Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 95 Singapore Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 96 Rest of Asia Pacific Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 97 Latin America Synthetic Immunology Market Attractiveness Index
• Figure 98 Latin America Synthetic Immunology Market by Region, 2024, 2029 & 2034 (US$ Billion)
• Figure 99 Latin America Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
• Figure 100 Latin America Synthetic Immunology Market Share Forecast by Country, 2024 & 2034 (%)
• Figure 101 Latin America Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
• Figure 102 Latin America Synthetic Immunology Market Share Forecast by Type, 2024 & 2034 (%)
• Figure 103 Latin America Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
• Figure 104 Latin America Synthetic Immunology Market Share Forecast by Application, 2024 & 2034 (%)
• Figure 105 Latin America Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR %)
• Figure 106 Latin America Synthetic Immunology Market Share Forecast by End-User, 2024 & 2034 (%)
• Figure 107 Brazil Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 108 Mexico Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 109 Argentina Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 110 Colombia Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 111 Rest of Latin America Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 112 MEA Synthetic Immunology Market Attractiveness Index
• Figure 113 MEA Synthetic Immunology Market by Region, 2024, 2029 & 2034 (US$ Billion)
• Figure 114 MEA Synthetic Immunology Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
• Figure 115 MEA Synthetic Immunology Market Share Forecast by Country, 2024 & 2034 (%)
• Figure 116 MEA Synthetic Immunology Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
• Figure 117 MEA Synthetic Immunology Market Share Forecast by Type, 2024 & 2034 (%)
• Figure 118 MEA Synthetic Immunology Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
• Figure 119 MEA Synthetic Immunology Market Share Forecast by Application, 2024 & 2034 (%)
• Figure 120 MEA Synthetic Immunology Market Forecast by End-User, 2024-2034 (US$ Billion, AGR %)
• Figure 121 MEA Synthetic Immunology Market Share Forecast by End-User, 2024 & 2034 (%)
• Figure 122 GCC Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 123 South Africa Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 124 Rest of MEA Synthetic Immunology Market Forecast, 2024-2034 (US$ Billion, AGR %)
• Figure 125 ADC Therapeutics: Net Revenue, 2021-2023 (US$ Million, AGR %)
• Figure 126 ADC Therapeutics: R&D Expense, 2018-2023 (US$ Million, AGR %)
• Figure 127 ADC Therapeutics: SWOT Analysis
• Figure 128 BioNTech SE: Net Revenue, 2018-2023 (US$ Million, AGR %)
• Figure 129 BioNTech SE: R&D Expense, 2018-2023 (US$ Million, AGR %)
• Figure 130 BioNTech SE: SWOT Analysis
• Figure 131 CRISPR Therapeutics AG: Net Revenue, 2018-2023 (US$ Million, AGR %)
• Figure 132 CRISPR Therapeutics AG: SWOT Analysis
• Figure 133 Editas Medicine, Inc.: Net Revenue, 2018-2023 (US$ Million, AGR %)
• Figure 134 Editas Medicine, Inc.: SWOT Analysis
• Figure 135 Synthego: SWOT Analysis
• Figure 136 GenScript Biotech Corporation: Net Revenue, 2018-2023 (US$ Million, AGR %)
• Figure 137 GenScript Biotech Corporation: SWOT Analysis
• Figure 138 Ginkgo Bioworks: SWOT Analysis
• Figure 139 Inscripta, Inc.: SWOT Analysis
• Figure 140 Moderna, Inc.: Net Revenue, 2018-2023 (US$ Million, AGR %)
• Figure 141 Moderna, Inc.: R&D Expense, 2018-2023 (US$ Million, AGR %)
• Figure 142 Moderna, Inc.: SWOT Analysis
• Figure 143 Synlogic Therapeutics: SWOT Analysis
• Figure 144 Evonetix Ltd.: SWOT Analysis
• Figure 145 Sherlock Biosciences: SWOT Analysis
• Figure 146 Mission Therapeutics: SWOT Analysis
• Figure 147 Camena Bioscience: SWOT Analysis
• Figure 148 Mammoth Biosciences: SWOT Analysis

The global Synthetic Immunology market is projected to grow at a CAGR of 25.6% by 2034

The Synthetic Immunology Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Advancements in Biotechnology Driving Market Growth

Technological advancements in synthetic biology, gene editing, and immunotherapy have revolutionized the landscape of healthcare, particularly in the emerging field of synthetic immunology. Synthetic biology techniques provide researchers with unprecedented control over the design and construction of biological molecules, allowing for the creation of novel synthetic molecules tailored to specific therapeutic needs. Biopharmaceuticals are leading the charge within the industry, capturing over 41% of the market revenue in 2023. Biologics are surpassing traditional drugs in terms of new drug approvals by the FDA. By engineering synthetic antibodies, cytokines, and receptors, researchers can precisely target immune cells, pathways, or disease antigens with enhanced efficacy and specificity. Gene editing technologies, such as CRISPR-Cas9, enable researchers to modify the genetic code of immune cells, such as T cells, to enhance their ability to recognize and eliminate diseased cells. This targeted approach minimizes off-target effects and improves the overall effectiveness of immunotherapies.

High Development Costs of Synthetic Immunology Likely to Hamper Industry Growth

The development of synthetic immunotherapy and diagnostic tools entails significant investment in research and development (R&D) across multiple stages, from early discovery to clinical testing and regulatory approval. One of the primary cost drivers is the need for cutting-edge technology and expertise to design, engineer, and produce synthetic molecules with the desired therapeutic or diagnostic properties. This includes investment in sophisticated laboratory equipment, computational tools, and specialized personnel skilled in synthetic biology, gene editing, and immunology. Moreover, conducting clinical trials to evaluate the safety and efficacy of synthetic immunotherapy and diagnostic products represents a substantial portion of R&D costs. Clinical trials require extensive resources, including patient recruitment, data collection and analysis, and compliance with regulatory standards for Good Clinical Practice (GCP).

What Questions Should You Ask before Buying a Market Research Report?

How is the synthetic immunology market evolving?

What is driving and restraining the synthetic immunology market?

How will each synthetic immunology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each synthetic immunology submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading synthetic immunology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the synthetic immunology projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of synthetic immunology projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the synthetic immunology market?

Where is the synthetic immunology market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the synthetic immunology market today, and over the next 10 years:

Our 257-page report provides 102 tables and 148 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type

Synthetic Antibodies

Synthetic Vaccines

Synthetic Adjuvants

Synthetic Immunomodulators

Others

Application

Infectious Diseases

Autoimmune Diseases

Cancer

Allergies

Others

End-users

Hospitals

Clinics

Research Institutes

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Singapore

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Synthetic Immunology Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

ADC Therapeutics

BioNTech SE

Camena Bioscience

CRISPR Therapeutics AG

Editas Medicine, Inc.

Evonetix Ltd.

GenScript Biotech Corporation

Ginkgo Bioworks

Inscripta, Inc.

Mammoth Biosciences

Mission Therapeutics

Moderna, Inc.

Sherlock Biosciences

Synlogic Therapeutics

Synthego

Overall world revenue for Synthetic Immunology Market, 2024 to 2034 in terms of value the market will surpass US$19.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Synthetic Immunology Market, 2024 to 2034 report help you?

In summary, our 250+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Synthetic Immunology Market, 2024 to 2034, with forecasts for type, application, end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 24 key national markets - See forecasts for the Synthetic Immunology Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Synthetic Immunology Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Synthetic Immunology Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Synthetic Immunology Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
• 3.3 Impact Analysis
  • 3.3.1 Market Driving Factors
    • 3.3.1.1 Advancements in Biotechnology
    • 3.3.1.2 Increasing Prevalence of Chronic Diseases
    • 3.3.1.3 Rapid Growth in Cancer Immunotherapy
  • 3.3.2 Market Restraining Factors
    • 3.3.2.1 High Development Costs of Synthetic Immunology
    • 3.3.2.2 Challenges in Regulatory Process
    • 3.3.2.3 Ethical Considerations of Synthetic Immunology
  • 3.3.3 Market Opportunities
    • 3.3.3.1 Growing Demand of Personalized Medicine
    • 3.3.3.2 Emerging Therapeutic Areas
    • 3.3.3.3 Growing Synthetic Vaccine Development
• 3.4 Supply Chain Analysis
• 3.5 Regulatory Framework
• 3.6 Emerging Markets and Megatrends
• 3.7 Porter's Five Forces Analysis
  • 3.7.1 Bargaining Power of Suppliers
  • 3.7.2 Bargaining Power of Buyers
  • 3.7.3 Competitive Rivalry
  • 3.7.4 Threat of Substitutes
  • 3.7.5 Threat of New Entrants
• 3.8 PEST Analysis

4 Synthetic Immunology Market Analysis by Type

• 4.1 Key Findings
• 4.2 Type Segment: Market Attractiveness Index
• 4.3 Synthetic Immunology Market Size Estimation and Forecast by Type
• 4.4 Synthetic Antibodies
  • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Synthetic Vaccines
  • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Synthetic Adjuvants
  • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Synthetic Immunomodulators
  • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)
• 4.8 Others
  • 4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 4.8.2 Market Share by Region, 2024 & 2034 (%)

5 Synthetic Immunology Market Analysis by Application

• 5.1 Key Findings
• 5.2 Application Segment: Market Attractiveness Index
• 5.3 Synthetic Immunology Market Size Estimation and Forecast by Application
• 5.4 Infectious Diseases
  • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Autoimmune Diseases
  • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Cancer
  • 5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)
• 5.7 Allergies
  • 5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.7.2 Market Share by Region, 2024 & 2034 (%)
• 5.8 Others
  • 5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Synthetic Immunology Market Analysis by End-User

• 6.1 Key Findings
• 6.2 End-users Segment: Market Attractiveness Index
• 6.3 Synthetic Immunology Market Size Estimation and Forecast by End-User
• 6.4 Hospitals
  • 6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.4.2 Market Share by Region, 2024 & 2034 (%)
• 6.5 Clinics
  • 6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.5.2 Market Share by Region, 2024 & 2034 (%)
• 6.6 Research Institutes
  • 6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.6.2 Market Share by Region, 2024 & 2034 (%)
• 6.7 Others
  • 6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
  • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Synthetic Immunology Market Analysis by Region

• 7.1 Key Findings
• 7.2 Regional Market Size Estimation and Forecast

8 North America Synthetic Immunology Market Analysis

• 8.1 Key Findings
• 8.2 North America Synthetic Immunology Market Attractiveness Index
• 8.3 North America Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 8.4 North America Synthetic Immunology Market Size Estimation and Forecast by Country
• 8.5 North America Synthetic Immunology Market Size Estimation and Forecast by Type
• 8.6 North America Synthetic Immunology Market Size Estimation and Forecast by Application
• 8.7 North America Synthetic Immunology Market Size Estimation and Forecast by End-User
• 8.8 U.S. Synthetic Immunology Market Analysis
• 8.9 Canada Synthetic Immunology Market Analysis

9 Europe Synthetic Immunology Market Analysis

• 9.1 Key Findings
• 9.2 Europe Synthetic Immunology Market Attractiveness Index
• 9.3 Europe Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 9.4 Europe Synthetic Immunology Market Size Estimation and Forecast by Country
• 9.5 Europe Synthetic Immunology Market Size Estimation and Forecast by Type
• 9.6 Europe Synthetic Immunology Market Size Estimation and Forecast by Application
• 9.7 Europe Synthetic Immunology Market Size Estimation and Forecast by End-User
• 9.8 Germany Synthetic Immunology Market Analysis
• 9.9 France Synthetic Immunology Market Analysis
• 9.10 UK Synthetic Immunology Market Analysis
• 9.11 Italy Synthetic Immunology Market Analysis
• 9.12 Spain Synthetic Immunology Market Analysis
• 9.13 Russia Synthetic Immunology Market Analysis
• 9.14 Rest of Europe Synthetic Immunology Market Analysis

10 Asia Pacific Synthetic Immunology Market Analysis

• 10.1 Key Findings
• 10.2 Asia Pacific Synthetic Immunology Market Attractiveness Index
• 10.3 Asia Pacific Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 10.4 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by Country
• 10.5 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by Type
• 10.6 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by Application
• 10.7 Asia Pacific Synthetic Immunology Market Size Estimation and Forecast by End-User
• 10.8 Japan Synthetic Immunology Market Analysis
• 10.9 China Synthetic Immunology Market Analysis
• 10.10 India Synthetic Immunology Market Analysis
• 10.11 Australia Synthetic Immunology Market Analysis
• 10.12 South Korea Synthetic Immunology Market Analysis
• 10.13 Singapore Synthetic Immunology Market Analysis
• 10.14 Rest of Asia Pacific Synthetic Immunology Market Analysis

11 Latin America Synthetic Immunology Market Analysis

• 11.1 Key Findings
• 11.2 Latin America Synthetic Immunology Market Attractiveness Index
• 11.3 Latin America Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 11.4 Latin America Synthetic Immunology Market Size Estimation and Forecast by Country
• 11.5 Latin America Synthetic Immunology Market Size Estimation and Forecast by Type
• 11.6 Latin America Synthetic Immunology Market Size Estimation and Forecast by Application
• 11.7 Latin America Synthetic Immunology Market Size Estimation and Forecast by End-User
• 11.8 Brazil Synthetic Immunology Market Analysis
• 11.9 Mexico Synthetic Immunology Market Analysis
• 11.10 Argentina Synthetic Immunology Market Analysis
• 11.11 Colombia Synthetic Immunology Market Analysis
• 11.12 Rest of Latin America Synthetic Immunology Market Analysis

12 MEA Synthetic Immunology Market Analysis

• 12.1 Key Findings
• 12.2 MEA Synthetic Immunology Market Attractiveness Index
• 12.3 MEA Synthetic Immunology Market by Country, 2024, 2029 & 2034 (US$ Billion)
• 12.4 MEA Synthetic Immunology Market Size Estimation and Forecast by Country
• 12.5 MEA Synthetic Immunology Market Size Estimation and Forecast by Type
• 12.6 MEA Synthetic Immunology Market Size Estimation and Forecast by Application
• 12.7 MEA Synthetic Immunology Market Size Estimation and Forecast by End-User
• 12.8 GCC Synthetic Immunology Market Analysis
• 12.9 South Africa Synthetic Immunology Market Analysis
• 12.10 Rest of MEA Synthetic Immunology Market Analysis

13 Company Profiles

• 13.1 Competitive Landscape, 2023
• 13.2 Strategic Outlook
• 13.3 ADC Therapeutics
  • 13.3.1 Company Snapshot
  • 13.3.2 Company Overview
  • 13.3.3 Financial Analysis
    • 13.3.3.1 Net Revenue, 2021-2023
    • 13.3.3.2 R&D Expense, 2018-2023
  • 13.3.4 Product Benchmarking
  • 13.3.5 Strategic Outlook
  • 13.3.6 SWOT Analysis
• 13.4 BioNTech SE
  • 13.4.1 Company Snapshot
  • 13.4.2 Company Overview
  • 13.4.3 Financial Analysis
    • 13.4.3.1 Net Revenue, 2018-2023
    • 13.4.3.2 R&D Expense, 2018-2023
  • 13.4.4 Product Benchmarking
  • 13.4.5 Strategic Outlook
  • 13.4.6 SWOT Analysis
• 13.5 CRISPR Therapeutics AG
  • 13.5.1 Company Snapshot
  • 13.5.2 Company Overview
  • 13.5.3 Financial Analysis
    • 13.5.3.1 Net Revenue, 2018-2023
  • 13.5.4 Product Benchmarking
  • 13.5.5 SWOT Analysis
• 13.6 Editas Medicine, Inc.
  • 13.6.1 Company Snapshot
  • 13.6.2 Company Overview
  • 13.6.3 Financial Analysis
    • 13.6.3.1 Net Revenue, 2018-2023
  • 13.6.4 Product Benchmarking
  • 13.6.5 Strategic Outlook
  • 13.6.6 SWOT Analysis
• 13.7 Synthego
  • 13.7.1 Company Snapshot
  • 13.7.2 Company Overview
  • 13.7.3 Product Benchmarking
  • 13.7.4 SWOT Analysis
• 13.8 GenScript Biotech Corporation
  • 13.8.1 Company Snapshot
  • 13.8.2 Company Overview
  • 13.8.3 Financial Analysis
    • 13.8.3.1 Net Revenue, 2018-2023
  • 13.8.4 Product Benchmarking
  • 13.8.5 Strategic Outlook
  • 13.8.6 SWOT Analysis
• 13.9 Ginkgo Bioworks
  • 13.9.1 Company Snapshot
  • 13.9.2 Company Overview
  • 13.9.3 Product Benchmarking
  • 13.9.4 Strategic Outlook
  • 13.9.5 SWOT Analysis
• 13.10 Inscripta, Inc.
  • 13.10.1 Company Snapshot
  • 13.10.2 Company Overview
  • 13.10.3 Product Benchmarking
  • 13.10.4 Strategic Outlook
  • 13.10.5 SWOT Analysis
• 13.11 Moderna, Inc.
  • 13.11.1 Company Snapshot
  • 13.11.2 Company Overview
  • 13.11.3 Financial Analysis
    • 13.11.3.1 Net Revenue, 2018-2023
    • 13.11.3.2 R&D Expense, 2018-2023
  • 13.11.4 Product Benchmarking
  • 13.11.5 Strategic Outlook
  • 13.11.6 SWOT Analysis
• 13.12 Synlogic Therapeutics
  • 13.12.1 Company Snapshot
  • 13.12.2 Company Overview
  • 13.12.3 Product Benchmarking
  • 13.12.4 SWOT Analysis
• 13.13 Evonetix Ltd.
  • 13.13.1 Company Snapshot
  • 13.13.2 Company Overview
  • 13.13.3 Product Benchmarking
  • 13.13.4 SWOT Analysis
• 13.14 Sherlock Biosciences
  • 13.14.1 Company Snapshot
  • 13.14.2 Company Overview
  • 13.14.3 Product Benchmarking
  • 13.14.4 SWOT Analysis
• 13.15 Mission Therapeutics
  • 13.15.1 Company Snapshot
  • 13.15.2 Company Overview
  • 13.15.3 Product Benchmarking
  • 13.15.4 SWOT Analysis
• 13.16 Camena Bioscience
  • 13.16.1 Company Snapshot
  • 13.16.2 Company Overview
  • 13.16.3 Product Benchmarking
  • 13.16.4 SWOT Analysis
• 13.17 Mammoth Biosciences
  • 13.17.1 Company Snapshot
  • 13.17.2 Company Overview
  • 13.17.3 Product Benchmarking
  • 13.17.4 SWOT Analysis

14 Conclusion and Recommendations

• 14.1 Concluding Remarks from Visiongain
• 14.2 Recommendations for Market Players